General methods
Peptide synthesis. Peptides 1, 2, 3, 4, and 5 were synthesized by automated synthesizer (CS136XT, C.S. Bio, Co.) as previously described.
1 Peptide hydrazides 1, 2, 4, and 5 were synthesized on hydrazine 2-chlorotrityl resin following the standard Fmoc-SPPS procedures. Peptide 3 that contains glycyl auxiliary group at Lys120 site could be assembled on Nova-PEG Wang resin through standard Fmoc SPPS. The reagents and materials were purchased as previously described. 1a,1c Reversed-Phase HPLC (RP-HPLC). All reversed phase HPLC were performed on Shimadzu Prominence HPLC (Prominence LC-20AT with SPD-20A UV/Vis detector). For peptide and reaction analysis, analytical Grace Vydac C4 (4.6 × 250 mm, 5 μm particle size) and C18 (4.6 × 150 mm, 5 μm particle size) columns were used at a flow rate of 1.0 mL/min. For peptide purifications, semi-preparative Grace Vydac C18 (10 × 250 mm, 10 μm particle size, flow rate of 3-4 mL/min) and semi-preparative Grace Vydac C18 (22 × 150 mm, 10 μm particle size, flow rate of 7-8 mL/min) were used. The UV absorption at 214 nm and 254 nm were monitored throughout the analysis and purifications. Mobile phase for RP-HPLC: buffer A (0.08-0.1% TFA in CH 3 CN) and buffer B (0.1% TFA in water). The solvents were sonicated for 25-30 min before use.
FPLC.
Size-exclusion chromatography (Superdex 200 column, 10/300 GL) and anion-exchange chromatography (DEAE column) were performed on an AKTA purifier (GE Healthcare Life Science) with Frac-900 detector.
Mass Spectrometry. The peptides and reaction products were characterized by normal ESI mass on Agilent 1200 Series HPLC system with LC-MS (Agilent 6340 ion trap as the mass spectrometer). The final product 11 was characterized by high-resolution ESI mass spectra and deconvoluted electrospray ionization mass spectra on Agilent 6210 Time of Flight Mass Spectrometer.
LC-MS/MS analysis.
The MS/MS identifications of H2BK120Ub were conducted as the protocols reported previously. 1c,2 Especially, the digestion of H2BK120Ub was conducted using sequencing Trypsin in 50 mM ammonium bicarbonate at 37 °C for 12 h. LC-MS/MS analysis was performed as previously described. The search criteria were as follows: full trypsin specificity was needed; the carbamidomethylation was set as the fixed modification; the oxidation (M) and GlyGly (K) were set as variable modifications; two missed cleavages were allowed; Fragment ion mass tolerance was 0.02 Da for all MS2 spectra. High confidence score filter (FDR <1%) was used to identify the "hit" peptide segments. We thank the protein chemistry facility at the Center for Biomedical Analysis of Tsinghua University for sample analysis.
General procedure for the native chemical ligation of peptide hydrazids. The native chemical ligation of peptide hydrazids were conducted as previously reported. 1a,1c The hydrazide peptide (1.0 equiv., final concentration 1-3 mM) was dissolved in acidic ligation buffer (the aqueous buffer containing 6 M guanidine hydrochloride (Gn·HCl) and 200 mM NaH 2 PO 4 , pH = 3.0). Then the above solution was cooled to -11 °C to -13 °C by an ice-salt bath. Then, the peptide solution was treated with 200 mM NaNO 2 solution (6.5 equiv., dissolved in the acidic ligation buffer) and subsequently stirred for 25-30 min (under -11 °C to -13 °C). Then, a solution of 65 equiv. of 200 mM MPAA (dissolved in the aqueous buffer containing 6 M Gn·HCl and 200 mM Na 2 HPO 4 , pH = 7.0) was added. The reaction mixture was then taken out from the ice-salt bath and stirred for 3 min at room temperature. Then, the Cys-peptide (1.0-1.2 equiv.) was added. Then, the pH value of reaction mixture was slowly adjusted to 6.5-6.9 with 2 M NaOH (aqueous solution). Then, the reaction was stirred at room temperature. Analytic RP-HPLC and ESI-MS were used to monitor the reaction process. After the completion of the reaction, the mixtures were treated with 200 mM TCEP (equal volumes to the reaction system). Finally, the ligation product was purified by semi-preparative RP-HPLC and lyophilized. Especially, the auxiliary-mediated ligation of peptide hydrazide between peptide 3 and peptide 6 was conducted as the protocols described above.
Reconstitution of octamers. Generally, the octamers containing H2BK120Ub were reconstituted under 4 °C as the methods described previously. 1a,3 Four histones (H2A, H2BK120Ub, H3, H4) were dissolved respectively in the unfolding buffer (6 M Gn·HCl, 20 mM Tris·HCl, 5 mM dithiothreitol, pH 7.5) at a concentration of 2 mg/mL. After about one hour incubation at room temperature, equimolar ratios of H2A, H2BK120Ub, H3, H4 (1 to 3 mg respectively) solution were combined together in one tube. The combined solution was diluted to a concentration of 1 mg/mL with the unfolding buffer. Then, the solution was added into a dialysis bag and dialyzed with 600 mL of the refolding buffer (2 M NaCl, 10 mM Tris·HCl, 1 mM Na-EDTA, 5 mM 2-mercaptoethanol, pH 7.5) under 4 °C. After 36 hours (three changes of refolding buffer), the reconstitution solution was concentrated and purified by size-exclusion chromatography (Superdex 200, 10/300 GL column), applying the refolding buffer as the elution buffer. The 18% SDS-PAGE was used to analyze the fractions. The fractions should always be kept at 4 °C. Finally, the isolated octamers containing H2BK120Ub were used in the reconstitution of mono-nucleosomes.
Reconstitution of mono-nucleosome. Generally, the mono-nucleosome containing H2BK120Ub were reconstituted under 4 °C as the methods described previously. 1a,3 0.25 mg of 601 DNA and 0.9 equivalent of isolated octamers were added into the mixture of pre-calculated 5 M NaCl and TE buffer (10 mM Tris·HCl, 1 mM EDTA, 1 mM dithiothreitol, pH 7.5). The final concentration of NaCl was 2 M. The result solution was then added into a dialysis bag and dialyzed against 400 mL of the refolding buffer (2 M NaCl, 10 mM Tris·HCl, 1 mM Na-EDTA, 1 mM dithiothreitol, pH 7.5). Then, the buffer was slowly replaced by TE buffer (10 mM Tris·HCl, 1 mM EDTA, 1 mM dithiothreitol, pH 7.5) at a flow rate of 0.7 mL/min through a peristaltic pump. When the concentration of NaCl was reduced to about 0.1 M, the dialysis bag was dialyzed against 400 mL of TE buffer for 6 h. The nucleosomes were purified by anion-exchange column (TSKgel, DEAE-5PW). The fractions were then identified by Native-PAGE. Figure S1 . Characterization of synthetic peptide segment 1. The peptide 1 was purified by HPLC with an isolated yield of 12%. A) Analytical HPLC chromatogram (λ = 214 nm) of purified peptide 1. HPLC condition: a linear gradient of 10%-50% acetonitrile (with 0.08-0.1% TFA) in water (with 0.1% TFA) over 30 min (10% for 2 min, then 10%-50% for 30 min) on a Vydac C18 column. B) ESI-MS spectrum of purified peptide 1. The spectrum gave an observed mass of 6341.9 Da (calculated 6340.3 Da, average isotopes). Figure S11. Characterization of protein 11. The protein 11 was purified by HPLC with an isolated yield of 62%. The deconvoluted electrospray ionization mass spectrum of 11. The spectra gave an observed mass of 22321.5 Da (calculated 22321.5 Da, average isotopes). HPLC condition of Figure 2A in the main text: a linear gradient of 25%-60% acetonitrile (with 0.08-0.1% TFA) in water (with 0.1% TFA) over 30 min (25% for 2 min, then 25%-60% for 30 min) on a Vydac C18 column.
Characterizations of peptides 1-11

LC-MS/MS identification of H2BK120Ub
The resulting modified polypeptide from H2BK120Ub was digested by sequencing Trypsin protease to the specific piece: AVTK(GlyGly)YTSSK (fragment 1, GlyGly is the fragment of Ub at Lys120). The (LC-MS)/MS results of fragment 1 were shown in Figure S12 . The mass data were identical to that expected from the database. Figure S12 . (LC-MS)/MS of fragment 1 of H2BK120Ub. The MS/MS sequencing data verifies the specific formation of the Lys120 linked isopeptide bond with a false discovery rate <1%.
